Associated Papers
Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D et al.
Fundamental & Clinical Pharmacology, 2012
Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P et al.
Lung Cancer (amsterdam, Netherlands), 2007
Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour.
Tricker AR
Toxicology, 2003
Polymorphisms of CYP2A6 and its practical consequences.
Raunio H et al.
British Journal of Clinical Pharmacology, 2001
Select a paper to view details